annual EBITDA:
$66.75M+$17.76M(+36.25%)Summary
- As of today (July 1, 2025), LMAT annual EBITDA is $66.75 million, with the most recent change of +$17.76 million (+36.25%) on December 31, 2024.
- During the last 3 years, LMAT annual EBITDA has risen by +$19.17 million (+40.30%).
- LMAT annual EBITDA is now at all-time high.
Performance
LMAT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$15.53M-$4.63M(-22.95%)Summary
- As of today (July 1, 2025), LMAT quarterly EBITDA is $15.53 million, with the most recent change of -$4.63 million (-22.95%) on March 31, 2025.
- Over the past year, LMAT quarterly EBITDA has increased by +$1.27 million (+8.94%).
- LMAT quarterly EBITDA is now -22.95% below its all-time high of $20.16 million, reached on December 31, 2024.
Performance
LMAT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$68.03M+$1.27M(+1.91%)Summary
- As of today (July 1, 2025), LMAT TTM EBITDA is $68.03 million, with the most recent change of +$1.27 million (+1.91%) on March 31, 2025.
- Over the past year, LMAT TTM EBITDA has increased by +$15.31 million (+29.04%).
- LMAT TTM EBITDA is now at all-time high.
Performance
LMAT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LMAT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.3% | +8.9% | +29.0% |
| 3 y3 years | +40.3% | +50.8% | +44.2% |
| 5 y5 years | +146.4% | +166.9% | +160.1% |
LMAT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.8% | -22.9% | +128.1% | at high | +84.2% |
| 5 y | 5-year | at high | +146.4% | -22.9% | +140.0% | at high | +160.1% |
| alltime | all time | at high | +4628.5% | -22.9% | +172.5% | at high | +432.0% |
LMAT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $15.53M(-22.9%) | $68.03M(+1.9%) |
| Dec 2024 | $66.75M(+36.3%) | $20.16M(+29.4%) | $66.75M(+8.5%) |
| Sep 2024 | - | $15.57M(-7.1%) | $61.52M(+7.0%) |
| Jun 2024 | - | $16.76M(+17.6%) | $57.52M(+9.1%) |
| Mar 2024 | - | $14.26M(-4.5%) | $52.72M(+7.6%) |
| Dec 2023 | $48.99M(+32.7%) | $14.93M(+29.0%) | $48.99M(+19.9%) |
| Sep 2023 | - | $11.57M(-3.2%) | $40.87M(+8.2%) |
| Jun 2023 | - | $11.96M(+13.6%) | $37.77M(+1.7%) |
| Mar 2023 | - | $10.53M(+54.6%) | $37.15M(+0.6%) |
| Dec 2022 | $36.92M(-22.4%) | $6.81M(-19.7%) | $36.92M(-10.9%) |
| Sep 2022 | - | $8.48M(-25.2%) | $41.43M(-7.8%) |
| Jun 2022 | - | $11.34M(+10.0%) | $44.93M(-4.8%) |
| Mar 2022 | - | $10.30M(-9.0%) | $47.18M(-0.8%) |
| Dec 2021 | $47.58M(+28.4%) | $11.31M(-5.6%) | $47.58M(-1.5%) |
| Sep 2021 | - | $11.98M(-11.8%) | $48.30M(-1.5%) |
| Jun 2021 | - | $13.59M(+27.1%) | $49.05M(+17.0%) |
| Mar 2021 | - | $10.69M(-11.2%) | $41.94M(+13.2%) |
| Dec 2020 | $37.06M(+36.8%) | $12.04M(-5.4%) | $37.06M(+17.1%) |
| Sep 2020 | - | $12.73M(+96.6%) | $31.65M(+21.0%) |
| Jun 2020 | - | $6.47M(+11.2%) | $26.15M(-3.5%) |
| Mar 2020 | - | $5.82M(-12.2%) | $27.12M(+0.4%) |
| Dec 2019 | $27.09M(-17.3%) | $6.63M(-8.4%) | $27.02M(-22.6%) |
| Sep 2019 | - | $7.24M(-2.7%) | $34.91M(+4.9%) |
| Jun 2019 | - | $7.43M(+30.0%) | $33.29M(+2.2%) |
| Mar 2019 | - | $5.72M(-60.6%) | $32.59M(-0.5%) |
| Dec 2018 | $32.77M(+30.1%) | $14.52M(+158.4%) | $32.77M(+27.6%) |
| Sep 2018 | - | $5.62M(-16.5%) | $25.68M(-1.7%) |
| Jun 2018 | - | $6.73M(+14.1%) | $26.12M(+0.8%) |
| Mar 2018 | - | $5.90M(-20.7%) | $25.91M(+2.9%) |
| Dec 2017 | $25.18M(+26.9%) | $7.43M(+22.8%) | $25.18M(+11.9%) |
| Sep 2017 | - | $6.06M(-7.1%) | $22.51M(-0.6%) |
| Jun 2017 | - | $6.52M(+26.0%) | $22.64M(+8.7%) |
| Mar 2017 | - | $5.17M(+8.6%) | $20.84M(+5.2%) |
| Dec 2016 | $19.85M(+33.9%) | $4.76M(-23.1%) | $19.81M(+2.6%) |
| Sep 2016 | - | $6.19M(+31.3%) | $19.31M(+14.2%) |
| Jun 2016 | - | $4.71M(+13.7%) | $16.90M(+6.8%) |
| Mar 2016 | - | $4.15M(-2.6%) | $15.82M(+6.8%) |
| Dec 2015 | $14.82M(+53.4%) | $4.26M(+12.4%) | $14.82M(+4.6%) |
| Sep 2015 | - | $3.79M(+4.2%) | $14.16M(+8.2%) |
| Jun 2015 | - | $3.63M(+15.7%) | $13.09M(+4.9%) |
| Mar 2015 | - | $3.14M(-12.8%) | $12.47M(+20.7%) |
| Dec 2014 | $9.66M | $3.60M(+33.1%) | $10.33M(+19.6%) |
| Sep 2014 | - | $2.71M(-10.3%) | $8.64M(+16.0%) |
| Jun 2014 | - | $3.02M(+201.0%) | $7.45M(+15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $1.00M(-47.5%) | $6.45M(-9.5%) |
| Dec 2013 | $7.13M(+14.5%) | $1.91M(+26.2%) | $7.13M(+6.8%) |
| Sep 2013 | - | $1.51M(-25.2%) | $6.68M(-1.0%) |
| Jun 2013 | - | $2.02M(+20.2%) | $6.75M(+0.7%) |
| Mar 2013 | - | $1.68M(+15.6%) | $6.70M(+7.6%) |
| Dec 2012 | $6.23M(+7.6%) | $1.46M(-8.0%) | $6.23M(+1.7%) |
| Sep 2012 | - | $1.58M(-19.9%) | $6.12M(-12.6%) |
| Jun 2012 | - | $1.98M(+63.3%) | $7.00M(-0.8%) |
| Mar 2012 | - | $1.21M(-10.5%) | $7.06M(-4.2%) |
| Dec 2011 | $5.79M(+7.1%) | $1.35M(-45.0%) | $7.37M(+44.9%) |
| Sep 2011 | - | $2.46M(+20.9%) | $5.09M(+1.7%) |
| Jun 2011 | - | $2.04M(+34.0%) | $5.00M(-7.2%) |
| Mar 2011 | - | $1.52M(-263.2%) | $5.39M(-2.4%) |
| Dec 2010 | $5.41M(+47.7%) | -$931.00K(-139.1%) | $5.52M(-32.2%) |
| Sep 2010 | - | $2.38M(-1.8%) | $8.14M(+7.3%) |
| Jun 2010 | - | $2.42M(+46.8%) | $7.58M(+14.0%) |
| Mar 2010 | - | $1.65M(-2.2%) | $6.65M(+81.4%) |
| Dec 2009 | $3.66M(-413.6%) | $1.69M(-7.5%) | $3.67M(+118.3%) |
| Sep 2009 | - | $1.82M(+22.2%) | $1.68M(+210.0%) |
| Jun 2009 | - | $1.49M(-211.8%) | $542.00K(-156.0%) |
| Mar 2009 | - | -$1.33M(+343.2%) | -$967.00K(-17.1%) |
| Dec 2008 | -$1.17M(-20.8%) | -$301.00K(-143.9%) | -$1.17M(-5.4%) |
| Sep 2008 | - | $685.00K(-4129.4%) | -$1.23M(-43.7%) |
| Jun 2008 | - | -$17.00K(-98.9%) | -$2.19M(-7.2%) |
| Mar 2008 | - | -$1.53M(+316.8%) | -$2.36M(+60.3%) |
| Dec 2007 | -$1.47M(-266.4%) | -$368.00K(+34.8%) | -$1.47M(+23.9%) |
| Sep 2007 | - | -$273.00K(+46.8%) | -$1.19M(+395.4%) |
| Jun 2007 | - | -$186.00K(-71.2%) | -$240.00K(-62.7%) |
| Mar 2007 | - | -$646.00K(+669.0%) | -$643.00K(-175.1%) |
| Dec 2006 | $886.00K(-66.3%) | -$84.00K(-112.4%) | $856.00K(-104.2%) |
| Sep 2006 | - | $676.00K(-214.8%) | -$20.49M(+53.5%) |
| Jun 2006 | - | -$589.00K(-169.1%) | -$13.35M(+155.3%) |
| Mar 2006 | - | $853.00K(-104.0%) | -$5.23M(-468.2%) |
| Dec 2005 | $2.63M(+2.7%) | -$21.43M(-374.1%) | $1.42M(-70.4%) |
| Sep 2005 | - | $7.82M(+3.9%) | $4.80M(+36.1%) |
| Jun 2005 | - | $7.53M(+0.4%) | $3.53M(+38.6%) |
| Mar 2005 | - | $7.50M(-141.6%) | $2.55M(+60.0%) |
| Dec 2004 | $2.56M(-87.6%) | -$18.05M(-375.7%) | $1.59M(-91.9%) |
| Sep 2004 | - | $6.55M(0.0%) | $19.64M(+50.0%) |
| Jun 2004 | - | $6.55M(0.0%) | $13.09M(+100.0%) |
| Mar 2004 | - | $6.55M | $6.55M |
| Dec 2003 | $20.66M(+2380.7%) | - | - |
| Dec 2002 | $833.00K(-395.4%) | - | - |
| Dec 2001 | -$282.00K | - | - |
FAQ
- What is LeMaitre Vascular annual EBITDA?
- What is the all time high annual EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular annual EBITDA year-on-year change?
- What is LeMaitre Vascular quarterly EBITDA?
- What is the all time high quarterly EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly EBITDA year-on-year change?
- What is LeMaitre Vascular TTM EBITDA?
- What is the all time high TTM EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular TTM EBITDA year-on-year change?
What is LeMaitre Vascular annual EBITDA?
The current annual EBITDA of LMAT is $66.75M
What is the all time high annual EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high annual EBITDA is $66.75M
What is LeMaitre Vascular annual EBITDA year-on-year change?
Over the past year, LMAT annual EBITDA has changed by +$17.76M (+36.25%)
What is LeMaitre Vascular quarterly EBITDA?
The current quarterly EBITDA of LMAT is $15.53M
What is the all time high quarterly EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly EBITDA is $20.16M
What is LeMaitre Vascular quarterly EBITDA year-on-year change?
Over the past year, LMAT quarterly EBITDA has changed by +$1.27M (+8.94%)
What is LeMaitre Vascular TTM EBITDA?
The current TTM EBITDA of LMAT is $68.03M
What is the all time high TTM EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high TTM EBITDA is $68.03M
What is LeMaitre Vascular TTM EBITDA year-on-year change?
Over the past year, LMAT TTM EBITDA has changed by +$15.31M (+29.04%)